BridgeMD
New treatment option for Treadmill Walking
Official title Treadmill Oscillation Walking to Improve Weight Transfer During Gait Following Stroke
ClinicalTrials.gov ID: NCT05541705
What this study is testing
- What it's testing
- This study aims to determine the immediate and short-term effects of treadmill oscillation walking (TOW) exercise on hip and knee neuromechanics and gait characteristics in individuals post-stroke. It was hypothesized that compared to baseline, individuals poststroke (N=15) will show increased hip abductor and knee extensor muscle activity and torque production, and increased limb loading and walking speeds during TOW and following a 6-week TOW intervention, reflecting that TOW can enhance gait function through improved hip and knee neuromechanical activation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Hemiparesis as a result of a stroke greater than 6 months previous to the study;
- A single cortical or subcortical stroke
- Able to walk 10 meters with or without a walking aid
- Able to stand unsupported for 5 minutes
- Sufficient cognitive function to follow instruction and communicate with the investigators.
You likely can't join if
- Medical condition precluding participant in regular exercise, such as acute cardiac or respiratory conditions limiting activity and other health...
- Bilateral stroke or a previous stroke in the contralateral hemisphere;
- Had a history of multiple strokes;
- Cerebellar stroke;
- Lower extremity joint replacement;
- Bone or joint problems that limited their ability to walk;
See the full eligibility criteria
- Hemiparesis as a result of a stroke greater than 6 months previous to the study;
- A single cortical or subcortical stroke
- Able to walk 10 meters with or without a walking aid
- Able to stand unsupported for 5 minutes
- Sufficient cognitive function to follow instruction and communicate with the investigators.
- Reduced paretic limb loading more than 6% compared to the non-paretic limb during overground gait assessment
- Medical condition precluding participant in regular exercise, such as acute cardiac or respiratory conditions limiting activity and other health conditions significantly impacting the ability to walk beyond the effects...
- Bilateral stroke or a previous stroke in the contralateral hemisphere;
- Had a history of multiple strokes;
- Cerebellar stroke;
- Lower extremity joint replacement;
- Bone or joint problems that limited their ability to walk;
- A resting heart rate outside of the range of 40 to 100 beats per minute;
- A resting blood pressure outside of the range of 90/60 to 170/90 mm Hg;
- Neglect;
- Hemianopia;
- Unexplained dizziness during the past 6 months;
- Chest pain or shortness of breath without exertion;
- Pregnancy by self-report.
The study team makes the final eligibility decision.
Where it's taking place
- Austin, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Austin, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.